SYS-CON MEDIA Authors: Doug Masi, Mat Mathews, PR.com Newswire, David Smith, Tim Crawford

News Feed Item

Robotic Prostatectomy Yields Cleaner Surgical Margins

Study Finds That Robot-Assisted Radical Prostatectomy Is Associated With Fewer Positive Surgical Margins and Reduced Need for Secondary Treatment, Says Prostate Cancer Expert, David Samadi, MD

NEW YORK, NY -- (Marketwired) -- 03/20/14 -- A new prostate cancer study demonstrated that robotic prostate surgery produces fewer positive surgical margins and requires less use of additional cancer therapy within two years of the surgery.

In a UCLA-lead comparative review of robotic prostate surgery verses open surgery, the findings indicated that robotic surgery reduces the risk of positive surgical margins by 5 percent and also reduces the need for secondary prostate cancer treatment. David B. Samadi, MD, Chairman of Urology and Chief of Robotic Surgery at Lenox Hill Hospital, believes these findings have widespread implications.

"We continue to see evidence of robotic surgery success being amplified in the hands of experienced surgeons," Dr. Samadi said. Using his own enhanced procedure, the Samadi Modified Advanced Robotic Technique (SMART), he has successfully performed 5,600 robotic radical prostatectomies. "Successful and thorough removal of cancerous tissue depends on a variety of factors: the dexterity of robotic tools, a bloodless surgical field, and most importantly, a highly skilled and experienced surgeon," he said.

After surgery, the removed prostate tissue is assessed on the volume of cancer cells in the margins. A positive surgical margin indicates that some prostate cancer may remain in the body, thereby increasing the chances of metastasis or recurrence. Surgical margin results are often used to determine whether secondary treatment, such as radiation or hormone therapy, is necessary.

In this study, positive surgical margins were present in 13.6 percent of the 5,556 robotic surgery patients and 18.3 percent of the 7,878 open surgery patients. "Clean surgical margins mean a lower chance of disease recurrence, and may subsequently mean less follow-up care and fewer healthcare expenses. Collectively, the short- and long-term benefits of robotic prostate surgery are tremendous," stated Dr. Samadi.

The study findings appear online in European Urology, http://www.europeanurology.com/article/S0302-2838%2814%2900134-1/abstract/comparative-effectiveness-of-robot-assisted-versus-open-radical-prostatectomy-cancer-control

Dr. Samadi is internationally recognized for robotic surgery excellence. He performs SMART robotic prostate removal surgery at The Lenox Hill Hospital Prostate Cancer Center in New York City.

Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2547297

Add to Digg Bookmark with del.icio.us Add to Newsvine

David B. Samadi, M.D
Chairman of Urology
Chief of Robotic Surgery at Lenox Hill Hospital

Tel: 1-212-365-5000
Fax: 1-646-692-6744

Address:
485 Madison Avenue
21st floor
New York, NY 10022

http://www.roboticoncology.com/contact/

Twitter: @drdavidsamadi
https://twitter.com/drdavidsamadi

Google+: +DavidSamadi
https://plus.google.com/+DavidSamadi

Facebook: facebook.com/drdavidsamadi
https://www.facebook.com/drdavidsamadi

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.